| Literature DB >> 26705763 |
Michael Firbank1, Xenia Kobeleva1,2, George Cherry3, Alison Killen1, Peter Gallagher1, David J Burn1, Alan J Thomas1, John T O'Brien4, John-Paul Taylor1.
Abstract
Attentional and executive dysfunction contribute to cognitive impairment in both Lewy body dementia and Alzheimer's disease. Using functional MRI, we examined the neural correlates of three components of attention (alerting, orienting, and executive/conflict function) in 23 patients with Alzheimer's disease, 32 patients with Lewy body dementia (19 with dementia with Lewy bodies and 13 with Parkinson's disease with dementia), and 23 healthy controls using a modified Attention Network Test. Although the functional MRI demonstrated a similar fronto-parieto-occipital network activation in all groups, Alzheimer's disease and Lewy body dementia patients had greater activation of this network for incongruent and more difficult trials, which were also accompanied by slower reaction times. There was no recruitment of additional brain regions or, conversely, regional deficits in brain activation. The default mode network, however, displayed diverging activity patterns in the dementia groups. The Alzheimer's disease group had limited task related deactivations of the default mode network, whereas patients with Lewy body dementia showed heightened deactivation to all trials, which might be an attempt to allocate neural resources to impaired attentional networks. We posit that, despite a common endpoint of attention-executive disturbances in both dementias, the pathophysiological basis of these is very different between these diseases.Entities:
Keywords: Alzheimer's disease; Lewy body dementia; attention; attention network test; executive; functional MRI
Mesh:
Substances:
Year: 2015 PMID: 26705763 PMCID: PMC4784171 DOI: 10.1002/hbm.23100
Source DB: PubMed Journal: Hum Brain Mapp ISSN: 1065-9471 Impact factor: 5.038
Figure 1Task design for ANT task. Each trial was either initiated by no cue, a neutral or directional cue, followed by a target after a fixation period of variable length. The target was either congruent (all arrows pointing into one direction) or incongruent (one arrow pointing into the opposite direction). The participants were instructed to push a button depending on the direction of the majority of the arrows.
Demographics and clinical scores
| Controls ( | Alzheimer's disease ( | LBD ( | Between group differences ( | Between group post‐hoc tests | |
|---|---|---|---|---|---|
| Age | 76.3 (5.5) | 75.8 (8.2) | 75.0 (6.4) |
| – |
| Sex male:female | 16:7 | 20:4 | 27:5 |
| – |
| Duration (years) cognitive decline | – | 3.39 (1.61) | 3.33 (2.07) |
| – |
| Cholinesterase Inhibitors | 0 (0%) | 25 (100%) | 27 (84%) | Fisher p =0.068 | – |
| Positive DAT scan | – | – | 10/11 (91%) | – | |
| UPDRS | 1.3 (1.7) | 2.0 (1.7) | 19.06 (8.0) |
| Con = AD « LBD |
| Cornell | 0.59 (1.1) | 0.91 (1.1) | 2.97 (2.2) |
| Con = AD « LBD |
| MMSE | 29.1 (0.9) | 22.0 (3.2) | 23.4 (3.8) |
| – |
| CAMCOG | 96.8 (3.6) | 71.0 (11.7) | 76.7 (12.6) |
| – |
| CAMCOG executive | 23.0 (2.5) | 15.1 (4.1) | 13.3 (4.1) |
| – |
| MAYO fluctuations | 1.0 (1.0) | 2.35 (1.4) |
| – | |
| MAYO cognitive | 1.95 (1.9) | 2.71 (1.9) |
| – | |
| CAF total | – | 0.5 (1.4) | 4.81 (4.1) |
| – |
| 1 day fluctuation | 2.14 (2.4) | 3.59 (3.1) |
| – | |
| NPI | 6.2 (6.8) | 13.4 (10.0) |
| – | |
| Verbal fluency (FAS) | 43.7 (16.2) | 30.1 (15.5) | 20.5 (11.9) |
| Con » AD › LBD |
| Angle discrimination | 19.7 (0.8) | 19.4 (1.3) | 16.5 (4.7) |
| Con = AD » LBD |
Alzheimer's disease vs Lewy body dementia 2 group comparison.
ANOVA Post hoc (Tukey) group comparisons, AD, Alzheimer's disease; Con, controls.
‹ Indicates P < 0.05; « P < 0.01; = indicates P >=0.05.
Abbreviations: CAMCOG, Cambridge Cognitive Examination; MMSE, Mini ‐Mental State Examination; NPI, Neuropsychiatric Inventory; CAF, Clinician Assessment of Fluctuations Scale; UPDRS, Unified Parkinson's disease rating scale; FAS, fluency for words starting with F,A,& S; Cornell, Cornell depression in dementia rating scale.
Reaction times and accuracy
| Controls ( | Alzheimer's disease ( | LBD ( | Between group Anova (df = 2,75) comparison ( | Tukey Post hoc between group comparisons | |
|---|---|---|---|---|---|
| ANT trials responded % [range] | 99.6 (0.89) [96.8 – 100] | 95.9 (6.6) [74.5–100] | 96.7 (4.72) [78.7–100] |
| Con › AD =LBD |
|
| |||||
| No cue | 928 (177) | 1,152 (247) | 1,395 (300) |
| Con ‹ AD « LBD |
| Neutral cue | 896 (159) | 1,133 (261) | 1,391 (322) |
| Con « AD « LBD |
| Directional cue | 816 (178) | 1,060 (241) | 1,325 (330) |
| Con « AD « LBD |
| Congruent | 714 (121) | 897 (210) | 1,125 (262) |
| Con ‹ AD « LBD |
| All Incongruent | 1,044 (233) | 1,347 (312) | 1,652 (410) |
| Con « AD « LBD |
| Incongruent easy | 1,005 (217) | 1,229 (274) | 1,521 (391) |
| Con ‹ AD « LBD |
| Incongruent hard | 1,084 (265) | 1,477 (384) | 1,800 (486) |
| Con « AD ‹ LBD |
|
| |||||
| No cue | 98.4 (1.9) | 91.0 (8.3) | 89.2 (7.6) |
| Con » AD = LBD |
| Neutral cue | 98.6 (1.3) | 90.7 (9.2) | 87.7 (9.3) |
| Con » AD = LBD |
| Directional cue | 98.9 (1.5) | 91.8 (9.2) | 88.1 (8.4) |
| Con » AD = LBD |
| Congruent | 98.8 (1.3) | 94.9 (6.3) | 94.0 (6.3) |
|
Con › AD; Con » LBD; AD = LBD |
| All incongruent | 98.4 (1.4) | 87.4 (12.1) | 82.7 (12.3) |
| Con » AD = LDB |
| Incongruent easy | 98.2 (2.3) | 88.2 (13.1) | 84.6 (13.3) |
| Con » AD = LDB |
| Incongruent hard | 98.6 (1.5) | 86.7 (13.5) | 80.9 (14.5) |
| Con » AD = LDB |
|
| |||||
| Alerting | 32.1 (48)* | 19.8 (93)† | 4.7 (88)† | 0.5 | – |
| Orienting | 79.9 (55)** | 72.7 (83)** | 66.1 (95)** | 0.8 | – |
| Executive | 330 (151)** | 451 (191)** | 527 (203)** | 0.001 | LBD « Con; AD=Con; AD=LBD |
| Conflict | 79 (129)* | 248 (228)** | 279 (249)** | 0.003 | Con « LBD; Con « AD; AD=LBD |
|
| |||||
| Alerting | −0.17 (1.85) | 0.31 (6.35) | 1.48 (4.36) | 0.383 | – |
| Orienting | 0.25 (1.38) | 1.07 (3.44) | 0.39 (3.96) | 0.648 | – |
| Executive | 0.39 (1.25) | 7.50 (9.61)** | 11.24 (10.84)** | <0.001 | Con « LBD; Con « AD; AD=LBD |
| Conflict | −0.40 (2.73) | 1.46 (10.98) | 3.71 (13.02) | 0.347 | – |
Group means for reaction times (RT) and accuracy within and between different conditions (alerting = no cue – neutral cue, orienting = neutral cue – directional cue, executive = incongruent – congruent, conflict = hard — easy). The standard deviations are presented in brackets.
Within group one sample t test for difference between cues/targets:.
*P < 0.05.
**P < 0.001.
†Not significant (P > 0.15).
For the Tukey Post hoc comparisons in RT, AD, Alzheimer's disease; Con, controls.
‹ indicates P < 0.05; « P < 0.01; = indicates P >=0.0.5
Figure 2Alerting and orienting effects. Group maps of fMRI activation for alerting (neutral – no cue) for (a) Controls, (b) Alzheimer's disease, (c) LBD (dementia with Lewy bodies+Parkinson's disease with dementia) and for orienting (directional – neutral cue) for (d) Controls, (e) Alzheimer's disease, (f) LBD. Significantly activated voxels (P < 0.001 uncorrected) are overlaid on an age matched template in MNI space. Colour overlay is T statistic from −6 (blue) to +6 (yellow). [Color figure can be viewed in the online issue, which is available at http://wileyonlinelibrary.com.]
Figure 3Executive effect. Mean group activations and group contrasts during the contrast incongruent – congruent target. (a) Controls, (b) Alzheimer's disease, (c) LBD, (d) Control – AD, (e) Control – LBD, (f) LBD – AD. Significantly activated voxels (P < 0.001 uncorrected) are overlaid on an age matched template in MNI space. Colour overlay is T statistic from −6 (blue) to +6 (yellow). [Color figure can be viewed in the online issue, which is available at http://wileyonlinelibrary.com.]
Figure 4Conflict effect. Mean group activations and group contrasts during the contrast hard – easy congruent target. (a) Controls, (b) Alzheimer's disease, (c) LBD, (d) AD – Control, (e) LBD – Control. Significantly activated voxels (P < 0.001 uncorrected) are overlaid on an age matched template in MNI space. Colour overlay is T statistic from −6 (blue) to +6 (yellow). [Color figure can be viewed in the online issue, which is available at http://wileyonlinelibrary.com.]
Figure 5BOLD contrast for the parietal DMN region during target presentation. Parietal DMN ROI analysis showing the BOLD contrast for the parietal DMN region for each group. Error bars are SE. Asterisk indicates within group contrasts (*P<0.05, **P<0.01). Cross indicates between group contrasts (+ P < 0.05; ++ P < 0.01). [Color figure can be viewed in the online issue, which is available at http://wileyonlinelibrary.com.]
Figure 6Target activations following different cue conditions. Group activations in the ROIs to targets following different cues (no cue, neutral cue, directional cue). Significant within‐group differences for no‐cue versus neutral cue are marked by an asterix (**P < 0.01 and *P < 0.05) and for neutral versus directional cue by a cross (+ P < 0.05). [Color figure can be viewed in the online issue, which is available at http://wileyonlinelibrary.com.]